https://www.selleckchem.com/pr....oducts/ulixertinib-b
Results MSTO2P had significant diagnostic and prognostic value in HCC. MSTO2P was highly expressed in HCC tissues and cells, and MSTO2P increased HCC cell proliferation, invasion and metastasis. MSTO2P knockdown also increased E-cadherin expression and decreased N-cadherin and Vimentin expression. Additionally, MSTO2P increased the expressions of proteins in the PI3K/AKT/mTOR pathway, including PI3K, p-AKT and p-mTOR. Conclusion MSTO2P might be used as a potential target for diagnosing and curing HCC. MSTO2P may af
Like
Comment
Share
